Abstract:Objective To explore the clinical outcome of percutaneous microwave/radiofrequency ablation liver partition and portal vein embolization for planned hepatectomy (PAPEP) for the treatment of hepatocelullar carcinoma (HCC) with insufficient future liver remnant (FLR).Methods The retrospective descriptive research method was taken.The clinical data of 2 patients of giant primary HCC (FLR complicated with cirrhosis) who were admitted to the Zhejiang Province People's Hospital from November 2015 to January 2016 were collected.Treatment plan:ultrasound-guided percutaneous microwave ablation (PMA) or percutaneous radio-frequency ablation (PRA) was performed on patients under intravenous anesthesia,at the same time portal vein embolization (PVE) was conducted.FLR was measured by rescan of computed tomography (CT) at 7-9 days postoperatively,according to FLR hyperplasia and general situation of the patient,right trisegmentectomy and expanded right hemihepatectomy were implemented respectively.Observation indicatiors indicators included (1)standard liver volume (SLV) and FLR before PRA/PVE treatment,(2) liver function,body temperature,FLR and time of FLR hyperplasia after PRA/PVE treatment,(3)liver function,body temperature,complications,FLR and duration of hospital stay after hepatectomy.Follow-up using outpatient examination and telephone interview was performed to detect carcinoma recurrence and other follow-up contents up to March 2016.Results (1) Before PRA + PVE,SLVs of 2 patients were 1 103 mL and 1 132mL,FLRs of 2 patients were respectively 417 mL and 297 mL which occupied the SLV at the percentage of 37.8％ and 26.2％ respectively.(2) After PRA + PVE treatment,there were no changes in liver function and fever.After PRA + PVE treatment,FLR of 2 patients increased to 652 mLand 522 mL,respectively,which occupied the SLV at the percentage of 59.1％ and 46.1％ respectively,with increased rates of 56.4％ and 75.6％ and time of FLR hyperplasia of 10 days and 17 days.The two patients received successful hepatectomy,without intraoperative red blood cell infusion.(3) At postoperative day 3,albumin (Alb),alanine transaminase (ALT),aspartate transaminase (AST) and total bilirubin (TBil) of liver function were 28.0 g/L,63 U/L,39 U/L and 19.0 μmol/L in patient 1 with a temperature of 38 degree,and 24.3 g/L,78 U/L,11 U/L and 38.1 μmol/L in patient 2 with a normal temperature.Liver function of 2 patients was improved after conservative treatment.No severe complications were occurred.Rescan of CT showed the FLR of patients continued increasing.The duration of hospital stay of 2 patients was 10 days and 14 days,respectively.Conclusion PAPEP for HCC with insufficient FLR is safe and effective.

Percutaneous Ethanol Intratumoral Injection for Treatment of Small Primary Liver Cancer: Summary of 240 Cases

Evaluation of the Curative Effect of Transcatheter Arterial Chemoembolization Via Hepatic Artery Combined with Percutaneous Ethanol Injection for the Treatment of Primary Hepatocellular Carcinoma

Percutaneous Microwave Ablation Liver Partition and Portal Vein Embolization for Planned Hepatectomy (PAPEP) for Hilar Cholangiocarcinoma

Percutaneous microwave ablation liver partition and portal vein embolization for planned hepatectomy due to large gastrointestinal stromal tumor metastases: A case report.

Percutaneous microwave/ radiofrequency ablation liver partition and portal vein embolization for planned hepatectomy (PAPEP) for HCC and perihilar cholangiocarcinoma with insufficient future liver remnant:A report of 3 casess

[Percutaneous Microwave/Radiofrequency Ablation Liver Partition and Portal Vein Embolization for Planned Hepatectomy for Colorectal Liver Metastases with Insufficient Future Liver Remnant].

Systematic sequential therapy for <i>ex vivo</i> liver resection and autotransplantation: A case report and review of literature

Percutaneous Ethanol Injection for Postoperative Reccurent Tumor of Hepatocellular Carcinoma

Efficacy and Safety of Endoscopic Ultrasonography-Guided Interventional Treatment for Refractory Malignant Left-Sided Liver Tumors: A Case Series of 26 Patients

Ablation Of Hepatic Malignant Tumors With Irreversible Electroporation: A Systematic Review And Meta-Analysis Of Outcomes

CT-guided Percutaneous Ethanol Injection in Treatment of Metastatic Adrenal Tumors

Survival of Patients Receiving Radiofrequency Ablation or Ethanol Injection for Early-Stage Hepatocellular Carcinoma.

[The Combination of Percutaneous Iohexol-Ethanol Injection with Radiofrequency Ablation for the Treatment of Primary Liver Cancer in High-Risk Locations].

Experience with Liver Resection after Hepatic Arterial Chemoembolization for Hepatocellular Carcinoma.

Comparative Efficacy and Safety Between Ablative Therapies or Surgery for Small Hepatocellular Carcinoma: a Network Meta-Analysis.

Experimental research of percutaneous ethanol therapy with different concentration injections on hepatic vx2 tumor of rabbits

Long-term efficacy of percutaneous transhepatic cholangioscopy-guided photodynamic therapy for postoperative recurrent extrahepatic cholangiocarcinoma

Safety and efficacy of transcatheter arterial chemoembolization plus early sequential percutaneous radiofrequency ablation for the treatment of large primary liver cancer with hepatitis B cirrhosis:a single-center experience

[Effect of Liver Cirrhosis on Percutaneous Selective Portal Vein Embolization for Primary Liver Cancer].

Hepatocellular Carcinoma More Than 3 Cm in Diameter: A Systematic Review of Transcatheter Arterial Chemoembolization Plus Percutaneous Ethanol Injection Versus Transcatheter Arterial Chemoembolization Alone.

The study of necrosis range and safety by radiofrequency with or without percutaneous ethanol injection in patients with primary of secondary hepatic cancer